Weight-based dosing in medication use: what should we know?

References

• Joint Commission ResourcesJoint Commission International Accreditation Standards for Hospitals5th edOak Brook, ILJoint Commission Resources2013
   Google Scholar
• ECRI InstituteMedication safety: inaccurate patient weight can cause dosing errors Available from: https://www.ecri.org/components/PSOCore/Pages/PSONav0214.aspx. [updated February 1, 2014]Accessed December 19, 2015
   Google Scholar
• MasanjaIMSelemaniMKhatibRACorrect dosing of artemether-lumefantrine for management of uncomplicated malaria in rural Tanzania: do facility and patient characteristics matter?Malar J20131244624325267
   PubMed Web of Science ®Google Scholar
• RosiniJMGrovolaMRLevineBJJasaniNBPrescribing habits of vancomycin in the Emergency Department: are we dosing appropriately?J Emerg Med20134497998423466019
   PubMed Web of Science ®Google Scholar
• RitchieDJReichleyRMCanadayKLBaileyTCEvaluation and financial impact of imipenem/cilastatin dosing in elderly patients based on renal function and body weightJ Pharm Technol1993916010128045
   PubMedGoogle Scholar
• GibsonPSNewellKSamDXWeight-adjusted dosing of tinzaparin in pregnancyThromb Res2013131e71e7523245654
   PubMed Web of Science ®Google Scholar
• LuscombeDKFactors influencing plasma drug concentrationsJ Int Med Res197751 Suppl8297863093
   PubMed Web of Science ®Google Scholar
• HodkinsonJPLucasMLeeMHarrisonMLunnMPChapelHTherapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patientsClin Exp Immunol201518117918725731216
   PubMed Web of Science ®Google Scholar
• drugs.com [homepage on the Internet]Nadroparin calcium (Fraxiparine) [updated March 21, 2001] Available from: http://www.drugs.com/cons/fraxiparine.htmlAccessed December 19, 2015
   Google Scholar
• RxList [homepage on the Internet]Enoxaparin (Lovenox) [updated July 16, 2013]. Available from: http://www.rxlist.com/lovenox-drug/indications-dosage.htmAccessed December 19, 2015
   Google Scholar
• PriglingerUDelle KarthGGeppertAProphylactic anticoagulation with enoxaparin: is the subcutaneous route appropriate in the critically ill?Crit Care Med2003311405140912771610
   PubMed Web of Science ®Google Scholar
• NunezJMBecherRDReboGJProspective evaluation of weight-based prophylactic enoxaparin dosing in critically ill trauma patients: adequacy of AntiXa levels is improvedAm Surg20158160560926031274
   PubMed Web of Science ®Google Scholar
• ChapmanSAIrwinEDReicksPBeilmanGJNon-weight-based enoxaparin dosing subtherapeutic in trauma patientsJ Surg Res201620118118726850200
   PubMed Web of Science ®Google Scholar
• RxList [hompage on the Internet]ZYVOX® [updated June 23, 2015]. Available from: http://www.rxlist.com/zyvox-drug/indications-dosage.htmAccessed December 19, 2015
   Google Scholar
• NiwaTWatanabeTSuzukiAReduction of linezolid-associated thrombocytopenia by the dose adjustment based on the risk factors such as basal platelet count and body weightDiagn Microbiol Infect Dis201479939724565849
   PubMed Web of Science ®Google Scholar
• MakiNOhkuchiATashiroYInitial dose of vancomycin based on body weight and creatinine clearance to minimize inadequate trough levels in Japanese adultsEur J Clin Microbiol Infect Dis2012312537254322391760
   PubMed Web of Science ®Google Scholar
• RxList [hompage on the Internet]Zemplar [updated May 20, 2011]. Available from: http://www.rxlist.com/zemplar-drug/indications-dosage.htmAccessed December 19, 2015
   Google Scholar
• MartinKJGonzálezELindbergJSParicalcitol dosing according to body weight or severity of hyperparathyroidism: a double-blind, multicenter, randomized studyAm J Kidney Dis200138S57S6311689389
   PubMed Web of Science ®Google Scholar
• MiaoLYangJHuangCShenZContribution of age, body weight, and CYP2C9 and VKORC1 genotype to the anticoagulant response to warfarin: proposal for a new dosing regimen in Chinese patientsEur J Clin Pharmacol2007631135114117899045
   PubMed Web of Science ®Google Scholar
• YooSHNahHWJoMWAge and body weight adjusted warfarin initiation program for ischaemic stroke patientsEur J Neurol2009161100110519614967
   PubMed Web of Science ®Google Scholar
• YooSHKwonSUJoMWKangDWKimJSAge- and weight-adjusted warfarin initiation nomogram for ischaemic stroke patientsEur J Neurol2012191547155322672718
   PubMed Web of Science ®Google Scholar
• JungJAKimTELeeHA proposal for an individualized pharmacogenetic-guided isoniazid dosage regimen for patients with tuberculosisDrug Des Devel Ther2015954335438
   PubMed Web of Science ®Google Scholar
• SubediATripathiMBhattaraiBKGuptaPKPokharelKRegmiMCThe effect of height and weight adjusted dose of intrathecal hyperbaric bupivacaine for elective caesarean sectionJNMA J Nepal Med Assoc2011511622335087
   PubMed Web of Science ®Google Scholar
• HartenJMBoyneIHannahPVarverisDBrownAEffects of a height and weight adjusted dose of local anaesthetic for spinal anaesthesia for elective Caesarean sectionAnaesthesia20056034835315766337
   PubMed Web of Science ®Google Scholar
• KovacsMJWeirKMacKinnonKKeeneyMBrienWFCruickshankMKBody weight does not predict for anti-Xa levels after fixed dose prophylaxis with enoxaparin after orthopedic surgeryThromb Res1998911371429733157
   PubMed Web of Science ®Google Scholar
• SarichTCTengRPetersGRNo influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatranClin Pharmacokinet20034248549212739986
   PubMed Web of Science ®Google Scholar
• UpretiVVWangJBarrettYCEffect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjectsBr J Clin Pharmacol20137690891623488672
   PubMed Web of Science ®Google Scholar
• KubitzaDBeckaMZuehlsdorfMMueckWBody weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjectsJ Clin Pharmacol20074721822617244773
   PubMed Web of Science ®Google Scholar
• YamashitaTKoretsuneYYasakaMRandomized, multicenter, warfarin-controlled phase II study of edoxaban in Japanese patients with non-valvular atrial fibrillationCirc J2012761840184722664798
   PubMed Web of Science ®Google Scholar
• RxList [homepage on the Internet]Remicade [updated October 9, 2015]. Available from: http://www.rxlist.com/remicade-drug.htmAccessed December 19, 2015
   Google Scholar
• RxList [homepage on the Internet]Humira [updated September 23, 2015]. Available from: http://www.rxlist.com/humira-drug.htmAccessed December 19, 2015
   Google Scholar
• BhalmeMSharmaAKeldRWillertRCampbellSDoes weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn’s disease?Eur J Gastroenterol Hepatol20132554354923337170
   PubMed Web of Science ®Google Scholar
• PayneDAJonesCIHayesPDNaylorARGoodallAHTherapeutic benefit of low-dose clopidogrel in patients undergoing carotid surgery is linked to variability in the platelet adenosine diphosphate response and patients’ weightStroke2007382464246917656657
   PubMed Web of Science ®Google Scholar
• WagnerHAngiolilloDJTen BergJMHigher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patientsJ Thromb Thrombolysis20143812713624043374
   PubMed Web of Science ®Google Scholar
• AngiolilloDJFernández-OrtizABernardoEPlatelet aggregation according to body mass index in patients undergoing coronary stenting: should clopidogrel loading-dose be weight adjusted?J Invasive Cardiol20041616917415152138
   PubMedGoogle Scholar
• OlivierCBSchnabelKWeberSPlatelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrelJ Thromb Thrombolysis Epub222016
   Web of Science ®Google Scholar
• RxList [homepage on the Internet]Herceptin [updated May 14, 2015]. Available from: http://www.rxlist.com/herceptin-drug/indications-dosage.htmAccessed February 19, 2016
   Google Scholar
• RxList [homepage on the Internet]Perjeta [updated June 12, 2015]. Available from: http://www.rxlist.com/perjeta-drug/indications-dosage.htmAccessed February 19, 2016
   Google Scholar
• GargAQuartinoALiJPopulation pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumorsCancer Chemother Pharmacol20147481982925119184
   PubMed Web of Science ®Google Scholar
• GuptaMLorussoPMWangBClinical implications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancerJ Clin Pharmacol20125269170321953571
   PubMed Web of Science ®Google Scholar
• QuartinoALHillenbachCLiJPopulation pharmacokinetic and exposure-response analysis for trastuzumab administered using a subcutaneous “manual syringe” injection or intravenously in women with HER2-positive early breast cancerCancer Chemother Pharmacol201677778826645407
   PubMed Web of Science ®Google Scholar
• PivotXGligorovJMüllerVPatients’ preferences for subcutaneous trastuzumab versus conventional intravenous infusion for the adjuvant treatment of HER2-positive early breast cancer: final analysis of 488 patients in the international, randomized, two-cohort PrefHer studyAnn Oncol2014251979198725070545
   PubMed Web of Science ®Google Scholar
• JinJFZhuLLChenMThe optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injectionPatient Prefer Adherence2015992394226170642
   PubMed Web of Science ®Google Scholar
• MahPMJenkinsRCRostami-HodjeganAWeight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiencyClin Endocrinol (Oxf)20046136737515355454
   PubMed Web of Science ®Google Scholar
• HafermannMJKiserTHLydaCWeight-based versus set dosing of vancomycin for coronary artery bypass grafting or aortic valve surgeryJ Thorac Cardiovasc Surg20141471925193024521953
   PubMed Web of Science ®Google Scholar
• CatanzanoAPhillipsMDubrovskayaYHutzlerLBoscoJ3rdThe standard one gram dose of vancomycin is not adequate prophylaxis for MRSAIowa Orthop J20143411111725328469
   PubMedGoogle Scholar
• CaiYChaiDFalagasMEWeight-adjusted versus fixed dose of linezolid for Chinese healthy volunteers of higher and lower body weight: a Phase I pharmacokinetic and pharmacodynamic studyExpert Opin Investig Drugs201322309315
   PubMed Web of Science ®Google Scholar
• HamiltonRThaiXCAmeriDPaiMPOral bioavailability of linezolid before and after Roux-en-Y gastric bypass surgery: is dose modification necessary in obese subjects?J Antimicrob Chemother20136866667323160755
   PubMed Web of Science ®Google Scholar
• BeathSMNuttallGAFassDNOliverWCJrErethMHOyenLJPlasma aprotinin concentrations during cardiac surgery: full- versus half-dose regimensAnesth Analg20009125726410910828
   PubMed Web of Science ®Google Scholar
• NuttallGAFassDNOyenLJOliverWCJrErethMHA study of a weight-adjusted aprotinin dosing schedule during cardiac surgeryAnesth Analg20029428328911812685
   PubMed Web of Science ®Google Scholar
• ThaçiDBräutigamMKaufmannRWeidingerGPaulCChristophersEBody-weight-independent dosing of cyclosporine micro-emulsion and three times weekly maintenance regimen in severe psoriasis. A randomised studyDermatology200220538338812444336
   PubMed Web of Science ®Google Scholar
• CzechWBräutigamMWeidingerGSchöpfEA body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of lifeJ Am Acad Dermatol20004265365910727313
   PubMed Web of Science ®Google Scholar
• RxList [homepage on the Internet]NovoSeven® [updated January 12, 2009]. Available from: http://www.rxlist.com/novoseven-drug/indications-dosage.htmAccessed December 19, 2015
   Google Scholar
• RobbinsAFongJHallWDitchKRolfeSMillerMComparison of a low, fixed dose and a high, weight-based dose of recombinant factor VIIa in the treatment of warfarin-associated intracranial hemorrhageNeurocrit Care20142046646923595666
   PubMed Web of Science ®Google Scholar
• GranettoCRicciSMartoniAComparing the efficacy and safety of fixed versus weight-based dosing of epoetin alpha in anemic cancer patients receiving platinum-based chemotherapyOncol Rep2003101289129612883695
   PubMed Web of Science ®Google Scholar
• van KralingenSvan de GardeEMKnibbeCAComparative evaluation of atracurium dosed on ideal body weight vs total body weight in morbidly obese patientsBr J Clin Pharmacol201171344021143499
   PubMed Web of Science ®Google Scholar
• LeykinYPellisTLuccaMLomanginoGMarzanoBGulloAThe pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patientsAnesth Analg2004991086108915385355
   PubMed Web of Science ®Google Scholar
• MeyhoffCSLundJJenstrupMTShould dosing of rocuronium in obese patients be based on ideal or corrected body weight?Anesth Analg200910978779219690247
   PubMed Web of Science ®Google Scholar
• JönssonPSkärbyTHeldrupJSchrøderHHöglundPHigh dose methotrexate treatment in children with acute lymphoblastic leukaemia may be optimised by a weight-based dose calculationPediatr Blood Cancer201157414621425443
   PubMed Web of Science ®Google Scholar
• FeberJAl-MatrafiJFarhadiEVaillancourtRWolfishNPrednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent?Pediatr Nephrol2009241027103119165504
   PubMed Web of Science ®Google Scholar
• RamanVKrishnamurthySHarichandrakumarKTBody weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trialPediatr Nephrol20163159560426759000
   PubMed Web of Science ®Google Scholar
• WeidlePJAbramsEJGvetadzeRRivadeneiraEKlineMWA simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settingsPediatr Infect Dis J200625596416395105
   PubMed Web of Science ®Google Scholar
• SchrierLde KamMLMcKinnonRComparison of body surface area versus weight-based growth hormone dosing for girls with Turner syndromeHorm Res Paediatr20148131933024776754
   PubMed Web of Science ®Google Scholar
• VealGJErringtonJRowbothamSEAdaptive dosing approaches to the individualization of 13-cis-retinoic acid (isotretinoin) treatment for children with high-risk neuroblastomaClin Cancer Res20131946947923087409
   PubMed Web of Science ®Google Scholar
• Gürlek GökçebayDAzikFOzbekNClinical comparison of weight- and age-based strategy of dose administration in children receiving intravenous busulfan for hematopoietic stem cell transplantationPediatr Transplant20151930731525661259
   PubMed Web of Science ®Google Scholar
• WaradDRaoANMullikinTA retrospective analysis of outcomes of dalteparin use in pediatric patients: a single institution experienceThromb Res201513622923326026634
   PubMed Web of Science ®Google Scholar
• DonnanJRUngarWJMathewsMHancock-HowardRLRahmanPA cost effectiveness analysis of thiopurine methyltransferase testing for guiding 6-mercaptopurine dosing in children with acute lymphoblastic leukemiaPediatr Blood Cancer20115723123921344614
   PubMed Web of Science ®Google Scholar
• CharaniEGharbiMHicksonMLack of weight recording in patients being administered narrow therapeutic index antibiotics: a prospective cross-sectional studyBMJ Open20155e006092
   Web of Science ®Google Scholar
• HallWL2ndLarkinGLTrujilloMJHindsJLDelaneyKAErrors in weight estimation in the emergency department: comparing performance by providers and patientsJ Emerg Med20042721922415388205
   PubMed Web of Science ®Google Scholar
• SpicerKGibsonPBloeCCrossSJLeslieSJWeight assessment in cardiac patients: implications for prescription of low molecular weight heparinPostgrad Med J20098512412719351637
   PubMed Web of Science ®Google Scholar
• Pennsylvania Patient Safety Advisorymedication errors: significance of accurate patient weightsPa Patient Saf Advis2009611015 Available from: http://patientsafetyauthority.org/ADVISORIES/AdvisoryLibrary/2009/mar6(1)/Pages/10.aspxAccessed March 17, 2016
   Google Scholar
• SelvanVACalvertSHCavellGGlucksmanEKerinsMGonzalezJWeight-based N-acetylcysteine dosing chart to minimise the risk of calculation errors in prescribing and preparing N-acetylcysteine infusions for adults presenting with paracetamol overdose in the emergency departmentEmerg Med J20072448248417582039
   PubMed Web of Science ®Google Scholar
• McIntyreSMcD TaylorDGreeneSIntroduction of an N-acetylcysteine weight-based dosing chart reduces prescription errors in the treatment of paracetamol poisoningEmerg Med Australas201325283523379449
   PubMed Web of Science ®Google Scholar
• LiJUdyAAKirkpatrickCMLipmanJRobertsJAImproving vancomycin prescription in critical illness through a drug use evaluation process: a weight-based dosing intervention studyInt J Antimicrob Agents201239697222024354
   PubMed Web of Science ®Google Scholar
• MarquisKADeGradoJRLabonvilleSKubiakDWSzumitaPMEvaluation of a pharmacist-directed vancomycin dosing and monitoring pilot program at a tertiary academic medical centerAnn Pharmacother2015491009101425991831
   PubMed Web of Science ®Google Scholar
• HallABMonteroJCobianJReganTThe effects of an electronic order set on vancomycin dosing in the EDAm J Emerg Med201533929425445870
   PubMed Web of Science ®Google Scholar
• RussellJMNick-DartRLNornholdBDDevelopment of a pharmacist-driven protocol for automatic medication dosage adjustments in obese patientsAm J Health Syst Pharm2015721656166326386107
   PubMed Web of Science ®Google Scholar
• BerryBBGearyDLJaffMRA model for collaboration in quality improvement projects: implementing a weight-based heparin dosing nomogram across an integrated health care delivery systemJt Comm J Qual Improv1998244594699770636
   PubMedGoogle Scholar